Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: We’re reading about plans for generic Wegovy, cough syrup warnings, and more

    Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
    by Ed Silverman Apr 19, 2024 1 minute
    Source: Alex Hogan/STAT

    And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still taking shape. However, we do, , , and . And what about you? This is a fine time to enjoy the great outdoors — a walk in the woods, a stroll along city streets, or a day at the shore may be in order. You could plan a summer getaway or tidy up around the castle. Or reach out to someone special. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
    A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
    BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.
    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

    Related Books & Audiobooks